Federico Bigazzi Selected Research

Federico Bigazzi Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2006
6	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2021 - 10/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 09/2004
6	Atherosclerosis 07/2016 - 01/2002
4	Homozygous Familial Hypercholesterolemia 01/2021 - 07/2016
4	Inflammation (Inflammations) 10/2011 - 01/2002
3	Hypercholesterolemia 10/2018 - 10/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 10/2018 - 08/2017
3	Myocardial Infarction 08/2017 - 01/2004
2	Heart Failure 08/2017 - 04/2007
2	Dyslipidemias (Dyslipidemia) 01/2017 - 01/2002
2	Coronary Disease (Coronary Heart Disease) 07/2016 - 12/2009
2	Xanthomatosis (Xanthoma) 07/2016 - 10/2013
2	Splenomegaly 10/2013 - 10/2012
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2013 - 12/2009
2	Left Ventricular Dysfunction 12/2012 - 12/2009
2	Tangier Disease 10/2012 - 04/2009
1	Acute Coronary Syndrome 01/2021
1	COVID-19 08/2020
1	Takotsubo Cardiomyopathy 01/2020
1	Cerebral Hemorrhage 01/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2018
1	Pulmonary Embolism 08/2015
1	Genetic Risk Score 05/2014
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 10/2013
1	Hyperlipidemias (Hyperlipidemia) 10/2013
1	Pancreatitis 10/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2013
1	Insulin Resistance 12/2012
1	Thrombocytopenia (Thrombopenia) 10/2012
1	Corneal Opacity 10/2012
1	Hepatomegaly 10/2012
1	Stroke (Strokes) 10/2012
1	Anemia 10/2012
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2012
1	Death (Near-Death Experience) 12/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2005
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 01/2002

Drug/Important Bio-Agent (IBA)

9	LipidsIBA 12/2021 - 12/2005
9	CholesterolIBA 08/2017 - 06/2005
6	Lipoproteins (Lipoprotein)IBA 01/2021 - 10/2013
6	HDL CholesterolIBA 08/2017 - 01/2004
6	HDL LipoproteinsIBA 10/2012 - 01/2004
5	oxidized low density lipoproteinIBA 11/2017 - 10/2011
4	LDL CholesterolIBA 01/2020 - 01/2013
3	Lipoprotein(a)IBA 03/2021 - 10/2018
2	Dipyridamole (Persantine)FDA LinkGeneric 01/2021 - 11/2017
2	Triglycerides (Triacylglycerol)IBA 01/2013 - 04/2009
2	Glucose (Dextrose)FDA LinkGeneric 12/2012 - 04/2007
2	C-Reactive ProteinIBA 12/2009 - 01/2002
1	ProteomeIBA 08/2017
1	PCSK9 InhibitorsIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	AntibodiesIBA 01/2017
1	BMS201038IBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2016
1	LDL Receptors (LDL Receptor)IBA 07/2016
1	Genetic Markers (Genetic Marker)IBA 05/2014
1	Heparin (Liquaemin)FDA LinkGeneric 10/2013
1	Insulin (Novolin)FDA Link 12/2012
1	DiureticsIBA 12/2012
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2012
1	Membrane Transport Proteins (Biological Pump)IBA 10/2012
1	Peroxidase (Myeloperoxidase)IBA 10/2011
1	Nonesterified Fatty Acids (NEFA)IBA 04/2007
1	Fenofibrate (CiL)FDA LinkGeneric 04/2007
1	PPAR alphaIBA 04/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2002

Therapy/Procedure

8	Blood Component Removal (Apheresis) 01/2021 - 10/2011
5	Therapeutics 01/2021 - 01/2017
1	Drug Therapy (Chemotherapy) 12/2021
1	Transjugular Intrahepatic Portasystemic Shunt 03/2021
1	Splenectomy 10/2013